Untitled - Roche Trasplantes

BIOPSIA DE PROTOCOLO EN EL TRASPLANTE RENAL
19. Marcusen N, Olsen TS, Benediktsson H y cols. Reproducibility of the Banff classification
of renal allograft pathology. Transplantation 1995; 60: 1083-9.
20. Furness PN, Taub N. International variation in the interpretation of renal transplant
biopsies: report of the CERTPAP project. Kidney Int 2001; 60: 1198-2010.
21. Colvin RB, Cohen AH, Saiontz C y cols. Evaluation of pathologic criteria for acute renal
allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc
Nephrol 1997; 8: 1930-41.
22. Veronese FV, Manfro RC, Roman FR y cols. Reproducibility of the Banff classification
in subclinical kidney transplant rejection. Clin transplant 2005; 19: 518-21.
23. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients.
Transplantation 1995; 59: 511-4.
24. Legendre C, Thervet E, Skiri H y cols. Histologic features of chronic allograft nephropathy
revealed by protocol biopsies in kidney transplant recipients. Transplantation
1998; 65: 1506-09.
25. Serón D, Moreso F, Ramón JM y cols. Protocol renal allografts biopsies and the design
of clinical trials aimed to prevent or treat chronic allograft nephropathy.
Transplantation 2000; 69: 1849-55.
26. Nankivell BJ, Fenton-Lee CA, Kuypers DR y cols. Effect of histological damage on
long-term kidney outcome. Transplantation 2001; 71: 515-21.
27. Serón D, Moreso F, Fulladosa X, Hueso M, Carrera M, Grinyó JM. Reliability of chronic
allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 2002; 61: 727-
33.
28. Roberts ISD, Reddy S, Russell C y cols. Subclinical rejection and borderline changes in early
protocol biopsies specimens after renal transplantation. Transplantation 2004; 77: 1194-8.
29. Choi BS, Shin MJ, Sjin SJ y cols. Clinical significance of an early protocol biopsy in living-donor
renal transplantation: ten-year experience at a single center. Am J Transplant
2005; 5: 1354-60.
30. Ishikawa MM, Mizuiri S, Aikawa A, Ohara T, Hasegawa A. Significance of subclinical
rejection in early renal allograft biopsies for chronic allograft dysfunction. Clin transplant
2005; 19: 456-65.
31. Nankivell BJ, Borrows RJ, Fung CLS, O’Connell PJ, Allen RDM, Chapman JR. Natural
history, risk factors, and impact of subclinical rejection in kidney transplantation.
Transplantation 2004; 78: 242-9.
32. Hueso M, Navarro E, Moreso F y cols. Relationship between subclinical rejection and
genotype, renal messenger RNA, and plasma protein transforming growth factor-β1
levels. Transplantation 2006 (en prensa).
33. Tinckam K, Rush D, Hutchinson I y cols. The relative importance of cytokine gene
polymorphisms in the development of early and late acute rejection and six-month
renal allograft pathology. Transplantation 2005; 79: 836-41.
34. Mytilineos J, Laux G, Opelz G. Relevance of IL10, TGFβ1, TNFα and IL4Rα gene polymorphisms
in kidney transplantation: a collaborative study report. Am J Transplant
2004; 4: 1684-71.
48